论文部分内容阅读
虽然国外早在50年代已开始进行心肌活检的研究,但直到1962年日本Sakakibara 及Ko-nno 首次报告以心导管式活检钳经静脉进行心内膜心肌活检(EMB)以后,才以其方法简便、安全,易为医师及病人接受,而得以在世界范围内广泛应用。目前EMB 已被公认为诊断心内膜心肌病变的主要方法之一。对疑为心内膜心肌疾患者,用通常的诊断方法得不到结果时即可做此项检查。EMB 的并发症为右室游离壁穿孔、心包填塞、气胸、栓塞(包括气栓)、血管迷走反应、感染、心律失常、暂时性喉返神经麻痹及
Although overseas studies on myocardial biopsy have begun in the 1950s, Sakhaibara and Ko-nno of Japan first reported the endocardial biopsy (EMB) through a cardiac catheterization biopsy forceps in 1962, , Safe, easy to physicians and patients to accept, and can be widely used in the world. EMB has now been recognized as one of the main methods of diagnosis of endocardial cardiomyopathy. For those suspected of endocardial cardiomyopathy, this test can be done when no result is obtained by the usual diagnostic methods. The complications of EMB were right ventricular free wall perforation, pericardial tamponade, pneumothorax, embolism (including embolism), vasovagal reaction, infection, arrhythmia, temporary laryngeal nerve palsy and